Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-23-124687

Chief Commercial Officer disposed of 1,082 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Francomano Robert Chief Commercial Officer 2023-12-06 Other disposition −1,082 $1.08 $1,169 20,918 D
Loading xslF345X05/tm2332459-2_4seq1.xml…